Zacks Investment Research Lowers Encompass Health (EHC) to Hold
Zacks Investment Research lowered shares of Encompass Health (AMEX:EHC) from a buy rating to a hold rating in a research note released on Tuesday.
According to Zacks, “Encompass Health Corporation provides inpatient rehabilitation hospitals and home-based care services. It offers facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. Encompass Health Corporation, formerly known as HealthSouth Corporation, is headquartered in Birmingham, Alabama. “
EHC has been the subject of several other reports. Royal Bank of Canada restated a buy rating on shares of Encompass Health in a research note on Wednesday, November 15th. Stephens set a $62.00 price target on Encompass Health and gave the stock a buy rating in a research note on Tuesday, February 27th. Piper Jaffray Companies restated a hold rating and issued a $59.00 price target on shares of Encompass Health in a research note on Thursday, March 1st. Credit Suisse Group upped their price target on Encompass Health from $58.00 to $61.00 and gave the stock an outperform rating in a research note on Tuesday, February 27th. Finally, Robert W. Baird reaffirmed a buy rating and set a $59.00 price objective on shares of Encompass Health in a report on Friday, January 12th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and seven have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and an average price target of $58.00.
Encompass Health (AMEX:EHC) last posted its quarterly earnings results on Monday, February 26th. The company reported $0.70 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.64 by $0.06. Encompass Health had a return on equity of 23.56% and a net margin of 8.67%. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1 billion. During the same period in the prior year, the company posted $0.72 EPS. The firm’s revenue for the quarter was up 7.3% compared to the same quarter last year. equities analysts anticipate that Encompass Health will post 2.72 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, April 16th. Stockholders of record on Monday, April 2nd will be issued a dividend of $0.25 per share. The ex-dividend date of this dividend is Thursday, March 29th. This represents a $1.00 annualized dividend and a dividend yield of 1.72%. Encompass Health’s dividend payout ratio (DPR) is 36.90%.
Several institutional investors and hedge funds have recently modified their holdings of the company. FNY Managed Accounts LLC purchased a new stake in shares of Encompass Health during the 4th quarter worth approximately $125,000. Cerebellum GP LLC purchased a new stake in Encompass Health during the 4th quarter valued at $129,000. Heartland Advisors Inc. purchased a new stake in Encompass Health during the 4th quarter valued at $237,000. Zeke Capital Advisors LLC purchased a new stake in Encompass Health during the 4th quarter valued at $238,000. Finally, S. R. Schill & Associates purchased a new stake in Encompass Health during the 4th quarter valued at $401,000. 93.18% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: This story was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://www.thecerbatgem.com/2018/03/14/zacks-investment-research-lowers-encompass-health-ehc-to-hold.html.
About Encompass Health
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.